Clinical Trial: Anti-mullerian Hormone in Acute Lymphoblastic Leukemia
Study Status: Completed
Recruit Status: RECRUITING
Condition: Acute Lymphoblastic Leukemia
Study Type: OBSERVATIONAL
Official Title: Anti-mullerian Hormone in Pediatric Patients Treated for Acute Lymphoblastic Leukemia
Brief Summary:
Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy, with current survival rates exceeding 90%.As cure rates improve, increasing attention is focused on survivor quality of life, including fertility.It is generally accepted that cancer treatments in childhood may interfere with gonadal function, reducing the pool of primordial follicles and consequently causing premature menopause in women.Anti-Mullerian hormone (AMH) levels is a valuable quantitative indicator of ovarian reserve, being…
Read more